Key takeaways
- Ozempic, Wegovy and other GLP-1 medications work by suppressing appetite.
- A 2022 study found that after people stopped taking Wegovy, they regained two-thirds of the weight they’d lost on the drug.
- Experts say GLP-1 medications should be considered long-term treatments for obesity, much like medications for high blood pressure, high cholesterol, or diabetes.
The recent swell of social media excitement about Ozempic and Wegovy have made the injectable weight loss medications household names. The so-called miracle weight-loss drugs have been in high demand and have even faced nationwide shortages.
